Formulation and Food Effect Study of AZD1386 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Pharmacokinetics
Interventions
DRUG

AZD1386

One single oral dose of 90mg (36mL of AZD1386 2.5mg/mL oral solution).

DRUG

AZD1386

One single oral dose of 90mg (3 x 30mg AZD1386 capsules)

DRUG

AZD1386

One single oral dose of 90mg (6 x 15mg AZD1386 tablets)

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY